10.50 - 11.12
3.81 - 12.83
1.80M / 1.60M (Avg.)
158.14 | 0.07
View analysts' price targets and recommendations, and compare them with competitors.
$4.18
Analysts expect the stock price to decrease by 62.24%.
Buy
Positive consensus among analysts.
Analyze analyst forecasts for the company and compare them with competitors.
897.00M
The estimated revenue has increased from the previous period.
247.65M
The estimated EBITDA has increased from the previous period.
1.09
The estimated EPS has increased from the previous period.
363.49M
The estimated net income has increased from the previous period.
190.09M
The estimated EBIT has increased from the previous period.
630.50M
The estimated SG&A expenses have increased from the previous period.
Analyze DCF forecasts for the company and compare them with competitors.
496.38M
Revenue has increased from the previous period.
41.92%
Revenue growth rate is unchanged from the previous period.
137.04M
EBITDA has increased from the previous period.
27.61%
EBITDA margin is unchanged from the previous period.
105.19M
EBIT has increased from the previous period.
21.19%
EBIT margin is unchanged from the previous period.
134.83M
Depreciation has increased from the previous period.
334.77M
Total cash has increased from the previous period.
67.44%
Cash percentage is unchanged from the previous period.
212.32M
Receivables have increased from the previous period.
42.77%
Receivables percentage is unchanged from the previous period.
230.80M
Inventories have increased from the previous period.
46.50%
Inventory percentage is unchanged from the previous period.
209.36M
Accounts payable has increased from the previous period.
42.18%
Payables percentage is unchanged from the previous period.
-125.71M
Capital expenditure has increased from the previous period.
-25.33%
CapEx percentage is unchanged from the previous period.
9.16%
WACC is unchanged from the previous period.
9.08%
Cost of equity is unchanged from the previous period.
293.12%
Cost of debt is unchanged from the previous period.
1.06
Beta is unchanged from the previous period.
333.90M
Diluted shares outstanding is unchanged from the previous period.
1.56M
Total debt is unchanged from the previous period.
3.49B
Total equity is unchanged from the previous period.
3.49B
Total capital is unchanged from the previous period.
0.04%
Debt weighting is unchanged from the previous period.
99.96%
Equity weighting is unchanged from the previous period.
64.98M
EBIAT has increased from the previous period.
5.06M
UFCF has increased from the previous period.
2.00%
Long-term growth rate is unchanged from the previous period.
205.99M
Terminal value is unchanged from the previous period.
73.57M
Enterprise value is unchanged from the previous period.
-113.70M
Net debt is unchanged from the previous period.
187.27M
Equity value is unchanged from the previous period.
0.56
Equity value per share is unchanged from the previous period.
